Search results
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 14 hours agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
Geron stock steady as analysts maintain 'buy' rating with $10 target By Investing.com
Investing.com· 11 hours agoOn Friday, TD (TSX:TD) Cowen reaffirmed its confidence in Geron (NASDAQ:GERN) Corporation (NASDAQ:...
Why Is Geron (GERN) Stock Up 18% Today?
InvestorPlace· 15 hours agoGeron (NASDAQ:GERN) stock is heading higher on Friday after getting approval from the U.S. Food and Drug Administration (FDA) for RYTELO. RYTELO is the...
Very good news for Geron stock price: now what? | Invezz
Invezz· 18 hours agoGeron Corporation (NASDAQ: GERN) stock price went vertical on Friday as investors cheered the latest...
FDA Reverses Juul Ban. What Comes Next?
InvestorPlace· 15 hours agoThe U.S.Food and Drug Administration (FDA) has changed its tone on Juul e-cigarettes and vapes as it reverses the ban it put in place on these products...
...Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with...
Benzinga· 1 day agoApproval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast (RS) status Durable and sustained red blood cell transfusion
Geron Corp stock opened 25% up on Friday: here's why | Invezz
Invezz· 15 hours agoAre you looking for signals & alerts from pro-traders? The Food & Drug Administration approved its lead asset as a late-line treatment for myelodysplastic syndromes (MDS). The telomerase inhibitor ...
Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers
Investopedia· 23 hours agoGeron (GERN) shares skyrocketed over 19% in intraday trading Friday after the Food and Drug...
Gold Falls Sharply; Geron Shares Spike Higher - GameStop (NYSE:GME)
Benzinga· 14 hours agoU.S. wholesale inventories increased by 0.1% month-over-month in April compared to the advance...
Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On...
Benzinga· 16 hours agoArgan posted quarterly earnings of 58 cents per share, beating market estimates of 52 cents per...